Project Grant R42DK115296

Summary Weill Medical College of Cornell University received a $843,179 Cooperative Agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded August 1, 2025, with completion targeted for June 30, 2029. The award supports research to decode cell-specific impacts of epigenomic regulation and alternative splicing mechanisms during Type 1 Diabetes (T1D) progression....

Summary of Federal Cooperative Agreement Award Joslin Diabetes Center, Inc. received a Cooperative Agreement award of $826,321 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 13, 2026, with completion anticipated by March 31, 2028. The award supports research to identify and develop renalase (RNLS) as a therapeutic target for early-stage Type 1...

Federal Grant Award Summary The Jaeb Center for Health Research Foundation, Inc. received a $2.34 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 3, 2025, with completion scheduled for August 31, 2028. The project, titled "Care Partner-Assisted Implementation of Patch Hybrid Closed Loop Insulin Delivery for Older Adults...

Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Scripps Research Institute a $801,662 Project Grant effective August 15, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project investigates the initiation of anti-islet autoimmunity in Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease, with particular focus on understanding the role...

Federal Cooperative Agreement Summary The University of California, San Diego received a $2.26 million Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 11, 2025, with completion scheduled for August 31, 2028. The award funds a clinical research initiative to evaluate the safe use of sodium-glucose cotransporter inhibitors...

Federal Cooperative Agreement Summary The University of Pennsylvania received a $1.79 million Cooperative Agreement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 4, 2025, with completion targeted for August 31, 2027. This award supports research investigating beta cell death in early-stage Type 1 Diabetes (T1D) caused by innate immune response...

Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received a $868,670 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of February 15, 2026, and completion targeted for December 31, 2030. This award supports research on DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A)...

The federal Project Grant award R43DK137616 for $275,766.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds Biosurfaces Inc., a for-profit medical device company, to develop and evaluate an implantable, electrospun cell chamber device loaded with human pancreatic islets. The device aims to provide an immune-protected environment to support...

Federal Project Grant Award Summary Ann & Robert H Lurie Children's Hospital of Chicago received a $191,245 project grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 15, 2025, through May 31, 2030. The award supports the development of a predictive risk score for prediabetes and youth-onset Type 2 Diabetes (YT2D) through analysis of clinical...

Amdx Prognostx Inc. received a $791,145 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases within the Department of Health and Human Services. The award falls under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), which promotes biomedical research to improve understanding and treatment of diabetes, digestive, and kidney diseases. Under this award, Amdx Prognostx will develop an enzyme-linked immunosorbent assay...